← Back to patent-cliff list

CAS 1229236-85-4

4-((6-chloro-3-(4-chloro-2-fluorobenzyl)-2-methylimidazo[1,2-b]pyridazin-8-yl)methyl)morpholine

Codes: GAND-007

Application context (from source-drug indications)

Haematological malignancyGandotinibMyelofibrosisGandotinibMyeloproliferative neoplasmGandotinibEssential thrombocythaemiaGandotinibPolycythaemia veraGandotinib

Source drugs (routes using this intermediate)

DrugTierExpiry
GandotinibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.